Chronic Spontaneous Urticaria Market is segmented By Treatment (H1-antihistamines, H2 antihistamines...
Market Size in USD Bn
CAGR10.9%
Study Period | 2025-2032 |
Base Year of Estimation | 2024 |
CAGR | 10.9% |
Market Concentration | Medium |
Major Players | Roche, Novartis, Sanofi/Regeneron, AstraZeneca, Amgen and Among Others |
The chronic spontaneous urticaria market is estimated to be valued at USD 2.66 Bn in 2025 and is expected to reach USD 5.49 Bn by 2032, growing at a compound annual growth rate (CAGR) of 10.9% from 2025 to 2032. The increasing prevalence of chronic spontaneous urticaria and growing awareness about its treatment options are contributing to the growth of this market.